The genomes of viruses are available on the NCBI website; the accession numbers are given in Tables [1](#pone.0202054.t001){ref-type="table"} and [S1](#pone.0202054.s001){ref-type="supplementary-material"}. The raw sequence data is available at NCBI's Short Reads Archive under GenBank accession number SRP120619.

Introduction {#sec004}
============

Limited access to clean drinking water is an enduring health hazard that can exacerbate enteric and malnutrition problems. Diarrhea also remains one of the leading causes of mortality in children from low and medium income countries \[[@pone.0202054.ref001]\].

Clean water and sanitation play an essential role in protecting human health during crisis and disease outbreaks. According to a WHO/UNICEF 2014 report, clean water sources were not available in 58% of Ethiopian rural areas. A National Water, Sanitation, and Hygiene Inventory from 2012 reported that only 32% of health facilities in Ethiopia have access to safe water. In Ethiopia, the children under five had a mortality rate of 59 deaths per 1,000 live births and diarrhea was the third leading cause of mortality in 2015 \[[@pone.0202054.ref002]--[@pone.0202054.ref005]\].

In this study we characterize the enteric viromes in children under-five years old in the Amhara region of Ethiopia in the context of a cluster-randomized trial of a water improvement intervention for trachoma. Description of these fecal viruses provide a baseline against which future viromes from the same population can be compared to monitor longitudinal changes in the composition and prevalence of circulating viruses.

Materials and methods {#sec005}
=====================

Study design {#sec006}
------------

The virome analysis described in this report is a non-pre-specified secondary analysis from a cluster-randomized trial of a water improvement intervention for trachoma (clinicaltrials.gov NCT02373657). The primary outcome for the trial was ocular chlamydia. Fourteen communities in rural Ethiopia were selected for the trial, with half randomized to a water point intervention and the other half randomized to no intervention. The intervention consisted of building a new hand dug water well in each community. Stool samples were collected from 0--5 year-old children during the final 24-month study visit of the trial.

Study population and selection {#sec007}
------------------------------

The cluster-randomized trial study took place in a rural agrarian region in the Goncha Siso Enese district (*woreda)* of Amhara, Ethiopia. *Woredas* in Ethiopia are divided into administrative units known as *kebeles*, and at the time of the study, *kebeles* were subdivided into government-defined units known as state teams. State teams, which consisted of approximately 275 people in our study area, are termed communities for this report.

Communities had been participating in a series of cluster-randomized trials testing different mass drug administration strategies for trachoma elimination since 2006 (clinicaltrials.gov \#NCT00322972). As part of these trials, 72 communities had received some form of mass azithromycin distribution for trachoma at least annually from 2010 to 2013. Methods for these trials are described in detail elsewhere \[[@pone.0202054.ref006]\]. From these 72 communities we randomly selected fourteen that were relatively accessible (\<1 hour walk from the farthest place a four-wheel drive vehicle could reach) and had poor access to water (only one or no water well). The baseline visit for the trial occurred in April 2014 and the final study visit occurred in April 2016. April is the dry season in this region.

A door-to-door population census was taken in all communities before the study visit. All children aged 0--5 years (i.e., up to but not including the sixth birthday) enumerated on the census were eligible to participate in the study.

Stool sample collection {#sec008}
-----------------------

Caregivers were instructed to have their child defecate in a plastic child's potty chair lined with a black plastic bag. For children unable to produce a stool within two hours, supplies were provided to the caregiver, with instructions to collect stool at home the following morning, and bring it to a collection site the following day at a designated time.

At the time the stool sample was returned, 0.5ml of stool was placed in a 1ml plastic tube. The sample was immediately put on ice and transferred to a -20 Celsius freezer at the end of the day. At the completion of the sample collection, in early May 2016, all samples were transferred to Bahir Dar Regional Laboratory (Bahir Dar, Ethiopia) and kept at -20 Celsius until they were shipped to University of California, San Francisco in February 2017.

Viral metagenomics {#sec009}
------------------

Approximately 0.1 gram of fecal matter from 269 stool samples were assembled into 29 pools of six to twelve samples either from villages with or without water improvement. To reduce possible batch effects, pools from the control and the intervention groups were processed in an inter-digitated manner. Pools were first clarified by 15,000g centrifugation for ten minutes, and supernatants filtered using a 0.45-μm filter (Millipore). Nucleic acids in the filtrates were digested with a mixture of nuclease enzymes and viral nucleic acids were then extracted using a Maxwell 16 automated extractor (Promega) \[[@pone.0202054.ref007]\]. Random RT-PCR followed by Nextera™ XT Sample Preparation Kit (Illumina) were used to generate a library for Illumina MiSeq (2 × 250 bases) with dual barcoding as previously described \[[@pone.0202054.ref008], [@pone.0202054.ref009]\].

Bioinformatic analyses {#sec010}
----------------------

### Overview {#sec011}

An in-house analysis pipeline was used to analyze sequence data. Raw data was first pre-processed by subtracting human and bacterial sequences, duplicate sequences, and low quality reads. The reads were de novo assembled and contigs and singlet reads were aligned against a customized viral proteome database using BLASTx. Candidate viral hits were then compared to a non-virus non-redundant (nr) protein database to remove false positive viral hits.

### Database compilation {#sec012}

To electronically subtract non-viral sequences the human reference genome sequence (hg38) and mRNA sequences were first concatenated. Bacterial nucleotide sequences were also extracted from NCBI nt fasta file \[[@pone.0202054.ref010]\] based on NCBI taxonomy \[[@pone.0202054.ref011]\]. Human and bacterial nucleotide sequences were then compiled into bowtie2 (version 2.2.4) databases \[[@pone.0202054.ref012]\] for human and bacterial sequences subtraction. Two databases were constructed: 1) virus BLASTx database was compiled using NCBI virus reference proteome \[[@pone.0202054.ref013]\] to which was added viral protein sequences from NCBI nr fasta file (based on annotation taxonomy in Virus Kingdom); and 2) a non-virus nr (NVNR) database was compiled using non-viral protein sequences extracted from NCBI nr fasta file (based on annotation taxonomy excluding Virus Kingdom). Repeats and low-complexity regions were masked using segmasker from blast+ suite (version 2.2.7)\[[@pone.0202054.ref014]\].

### Preprocessing {#sec013}

Paired-end reads of 250 bp generated by MiSeq were debarcoded using vendor software from Illumina. Human host reads and bacterial reads are identified and removed by mapping the raw reads to human reference genome hg38 and bacterial genomes release 66 using bowtie2 in local search mode with other parameters set as default, requiring finding 60bp aligned segments with at most 2 mismatches and no gaps \[[@pone.0202054.ref012]\]. Reads were considered duplicates if 5bp to 55bp from 5' end are identical. One random copy of duplicates was kept. Duplicate sequences were replaced with sequence 'A' as a place holder; preserving the original order of the paired-end files for paired-end sequence assembly. A paired-end sequence record is removed if both paired reads are deleted duplicates. Low sequencing quality tails were trimmed using Phred quality score 20 as the threshold. Adaptor and primer sequences were trimmed using the default parameters of VecScreen using default parameters \[[@pone.0202054.ref014]\].

### De novo assembly {#sec014}

We developed a strategy that integrates the sequential use of various de Bruijn graph (DBG) and overlap-layout-consensus assemblers (OLC) with a novel partitioned sub-assembly approach called ENSEMBLE \[[@pone.0202054.ref015]\].

Both single reads (singlets) and de novo assembled contiguously overlapping reads (contigs) were first analyzed using BLASTx (version 2.2.7) for translated protein sequence similarity to all viral protein sequences in GenBank's virus RefSeq database plus protein sequences taxonomically annotated as viral in GenBank's non-redundant database. An initially non-stringent E-value cutoff of [\<]{.ul}0.01 was selected in order to identify even weakly matching potential viral sequences. To remove background due to sequence misclassification these initial viral hits were then compared to all protein sequences in NR using the program DIAMOND (version 0.9.6) and retained only when the top hit was to a sequence annotated as viral. A threshold E score of \<10^−10^ was then used to ensure only reads with high levels of similarity to viral proteins were counted. Further analyses focused on eukaryotic viruses.

To align singlets and contigs to reference viral genomes from GenBank and generate complete or partial genome sequences the Geneious R10 program was used. For plotting read numbers to different viral clades the number of reads with BLASTx E score \<10^−10^ to named viruses was divided by the total number of reads multiplied by 10^4^ then log 10 transformed to determine the size of the colored circles using Excel.

Phylogenetic analyses {#sec015}
---------------------

Phylogenetic trees were constructed from VP1 amino acid sequence for picornaviruses or nucleotide for norovirus RdRp region. Evolutionary analyses were conducted in MEGA6 using the Neighbor-Joining method \[[@pone.0202054.ref016]\]. Percentage bootstrap values from 1000 replicate trees are shown \[[@pone.0202054.ref017]\]. All positions with less than 95% site coverage were eliminated.

Statistical methods {#sec016}
-------------------

All statistical analyses were performed in R version 3.4.2 (R Foundation for Statistical Computing, Vienna, Austria) using R Studio version 1.1.383. The number of virus matching singlets (E score [\<]{.ul}10^−10^) for each sample pool along with their viral taxonomic assignments and sample characteristics were analyzed using the 'phyloseq' package \[[@pone.0202054.ref018]\]. The 'phyloseq' package was used to calculate alpha diversity measures, which were then plotted using boxplots in 'ggplot'\[[@pone.0202054.ref019]\]. A Kruskal-Wallis test was then used to evaluate if differences in alpha diversity measures were statistically significant between the control and intervention groups.

Data availability {#sec017}
-----------------

The genomes of viruses are available on the NCBI website; the accession numbers are given in Tables [1](#pone.0202054.t001){ref-type="table"} and [S1](#pone.0202054.s001){ref-type="supplementary-material"}. The raw sequence data is available at NCBI's Short Reads Archive under GenBank accession number SRP120619.
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###### Characteristics of mammalian viral contigs.

![](pone.0202054.t001){#pone.0202054.t001g}

  Family                          *Genus*                  Species                      Genotypes             Pool ID \#                  GenBank accession number   Length of genome assembled (% sequenced)     Reference genome GenBank accession number    Region of reference genome covered             Nucleotide similarity with reference         aa idendity to VP1           
  ------------------------------- ------------------------ ---------------------------- --------------------- --------------------------- -------------------------- -------------------------------------------- -------------------------------------------- ---------------------------------------------- -------------------------------------------- -------------------- ------- ----------------------------------------------
  ***Picornaviridae***            Enterovirus              Enterovirus A                Coxsackievirus A6     P11                         MG692404                   3597 (100%)                                  KX064297                                     3712_7309                                      84.7%                                                                     
  P20                             MG692405                 3729 (61.1%)                 KX064297              922_7023                    82.1%                                                                                                                                                                                                                                         
  P22                             MG692406                 2782 (76.6%)                 KX064297              4216_7278                   84.8%                                                                                                                                                                                                                                         
  Coxsackievirus A14              P25                      MG692407                     5425 (77.7%)          KP036482                    197_7176                   82.6%                                                                                                                                                                                                              
  Coxsackievirus A16              P4                       MG692408                     2203 (82.8%)          JQ746670                    1950_4673                  85.0%                                                                                                                                                                                                              
  P11                             MF990299                 2607 (100%)                  JQ746670              1068_3674                   85.9%                      99.3%                                                                                                                                                                                                              
  P12                             MF990300                 7225 (100%)                  JQ746670              101_7325                    82.6%                      99.3%                                                                                                                                                                                                              
  Enterovirus B                   *Echovirus E6*           P17                          MG692409              4713 (77.5%)                KT353725                   23_6013                                      85.4%                                                                                                                                                                 
  P22                             MG692410                 2315 (73.9)                  HM852755              3631_6762                   83.2%                                                                                                                                                                                                                                         
  *Echovirus E14*                 P14                      MF990302                     6462 (100%)           AY302540                    1_6462                     79.8%                                        93.6%                                                                                                                                                                 
  P19                             MF990305                 7333 (99.2%)                 AY302540              1_6505                      79.9%                      93.6%                                                                                                                                                                                                              
  *Echovirus E16*                 P4                       MF990293                     7392 (100%)           AY302542                    24_7421                    80.6%                                        97.2%                                                                                                                                                                 
  P7                              MG525060-62              891 (49.4%)                  KP289436              1131_2933                   80.4%                                                                                                                                                                                                                                         
  Echovirus E18                   P12                      MF990301                     7270 (100%)           KX139457                    91_7362                    81.3%                                        94.8%                                                                                                                                                                 
  P18                             MG692411                 1642 (64.2%)                 KX139456              1317_3871                   80.3%                                                                                                                                                                                                                                         
  P26                             MG692412                 2982 (87.7%)                 KX139456              1311_4709                   80.7%                                                                                                                                                                                                                                         
  *Echovirus E19*                 P3                       MF990292                     7274 (100%)           AY302544                    70_7344                    79.4%                                        92.4%                                                                                                                                                                 
  P14                             MF990303                 3988 (99.2%)                 AY302544              1025_5053                   79.4%                      92.1%                                                                                                                                                                                                              
  *Echovirus E27*                 P8                       MF990295                     7167 (100%)           AY302551                    207_7376                   78.8%                                        89.2%                                                                                                                                                                 
  Enterovirus C                   *Coxsackievirus A1*      P8                           MF990294              7160 (100%)                 AF499635                   197_7357                                     83.2%                                        89.8%                                                                                                                    
  *Coxsackievirus A13*            P21                      MG692413                     3489 (65.4%)          JF260922                    1496_6832                  79.3%                                                                                                                                                                                                              
  *Coxsackievirus A17*            P9                       MF990296                     6215 (100%)           AF499639                    661_6875                   80.9%                                        95.0%                                                                                                                                                                 
  P18                             MG692414                 4076 (81.1%)                 AF499639              1216_6240                   79.4%                                                                                                                                                                                                                                         
  P26                             MF990306                 3147 (58.3%)                 AF499639              1774_7164                   80.9%                      93.4%                                                                                                                                                                                                              
  P28                             MF990307                 6525 (100%)                  AF499639              748_7272                    81.9%                      95.0%                                                                                                                                                                                                              
  *Coxsackievirus A20*            P9                       MF990297                     6082(100%)            DQ358078                    803_6885                   83.8%                                        97.6%                                                                                                                                                                 
  P10                             MF990298                 6541 (100%)                  DQ358078              311_6852                    83.3%                      98.3%                                                                                                                                                                                                              
  P15                             MG692415                 4040 (66.1%)                 DQ358078              732_6839                    83.5%                                                                                                                                                                                                                                         
  P16                             MF990304                 7280 (99.2%)                 DQ358078              55_7392                     84.5%                      98.0%                                                                                                                                                                                                              
  *Enterovirus C99*               P20                      MF990308                     1950 (96.2%)          EF015009                    1296_3320                  81.6%                                        94%\*                                                                                                                                                                 
  P13                             MG560270                 4280 (68.9)                  EF015009              852_7061                    82.4%                                                                                                                                                                                                                                         
  *Cosavirus*                     *Cosavirus A*            *cosavirus A_12*             P4                    MF621606                    3344 (68.3%)               JN867774                                     1_690                                        90.0%                                          96.8%[\*](#t001fn001){ref-type="table-fn"}                                
  * *                             P8                       MG692416                     1473 (50.4%)          FJ438902                    4069_6987                  90.9%                                                                                                                                                                                                              
  P10                             MG692417                 900 (50.5)                   FJ438902              5635_7416                   88.0%                                                                                                                                                                                                                                         
  *cosavirus A_8*                 P11                      MF621609                     6047 (88.3%)          JN867776                    1_905                      85.2%                                        98.2%[\*](#t001fn001){ref-type="table-fn"}                                                                                                                            
  *cosavirus A_5*                 P12                      MF621608                     5728 (91.3%)          JN867785                    1_694                      85.0%                                        97%\*                                                                                                                                                                 
  * *                             P14                      MG692418                     336 (100%)            FJ438904                    1234_1599                  86.3%                                                                                                                                                                                                              
  P16                             MG525054-56              1179 (38.49%)                FJ438902              4354_7416                   89.6%                                                                                                                                                                                                                                         
  P21                             MF621610                 1987 (56.4%)                 FJ438902              3850_7374                   86.9%                                                                                                                                                                                                                                         
  P25                             MG525057-59              1758 (35.8%)                 AB920345              1278_6182                   89.8%                                                                                                                                                                                                                                         
  *Cosavirus D*                   *Cosavirus D1*           P9                           MF621607              5330 (96.8%)                NC012802                   672_6173                                     83.0%                                        94.5%                                                                                                                    
  *Cosavirus E/D*                 * *                      P16.2                        MG692419              672 (100%)                  JN867757                   4699_5370                                    91.0%                                                                                                                                                                 
  P26                             MF621611                 2501 (81.5%)                 JN867757              3436_6501                   91.3%                                                                                                                                                                                                                                         
  *Cosavirus E*                   *Cosavirus E*            P2                           MF621605              2391 (77.7%)                FJ555055                   2770_5844                                    85.9%                                                                                                                                                                 
  *Parechovirus*                  *Human parechovirus 1*   * *                          P1                    MG438289                    5070 (74%)                 EF051629                                     254_7096                                     86.8%                                          96.9%                                                                     
  P5                              MG026486                 7041 (99%)                   EF051629              165_7272                    85.7%                      96.1%                                                                                                                                                                                                              
  P6                              MG026487                 7054 (100%)                  EF051629              203_7256                    85.4%                      96.5%                                                                                                                                                                                                              
  P13                             MG692434                 1597 (68.4%)                 EF051629              319_2653                    89.2%                                                                                                                                                                                                                                         
  P16                             MG026489                 7091 (99.5%)                 EF051629              159_7286                    83.1%                      96.5%                                                                                                                                                                                                              
  P21                             MG026491                 5965 (86.8%)                 EF051629              245_7115                    86.5%                      96.5%                                                                                                                                                                                                              
  P28                             MG026490                 7102 (100%)                  EF051629              173_7274                    85.7%                      96.1%                                                                                                                                                                                                              
  *Human parechovirus 4*          * *                      P3                           MG692433              1078 (96%)                  DQ315670                   568_1689                                     88.2%                                                                                                                                                                 
  *Human parechovirus 5*          * *                      P9                           MG026488              6877 (98.8%)                HQ696575                   148_7109                                     81.4%                                        92.8%                                                                                                                    
  *Human parechovirus 6*          * *                      P20                          MG438290              3506 (66.8%)                AB252582                   565_5812                                     94.6%                                        95.8%[\*](#t001fn001){ref-type="table-fn"}                                                                               
  *Human parechovirus 8*          * *                      P25                          MG026492              2622 (91.6%)                EU716175                   154_3006                                     82.8%                                        97.6%[\*](#t001fn001){ref-type="table-fn"}                                                                               
  *Human parechovirus 17*         * *                      P26                          MG438291              6606 (100%)                 KT319121                   334_6936                                     81.3%                                        97.3%                                                                                                                    
  *Hepatovirus*                   *Hepatovirus A*          Hepatovirus A_IB             P5                    MF621612                    3819 (78.1%)               M20273                                       1759_6642                                    93.9%                                          99.5%                                                                     
  P11                             MF621613                 4062(81.4%)                  M20273                1819_6807                   93.5%                      99.5%[\*](#t001fn001){ref-type="table-fn"}                                                                                                                                                                         
  P16                             MF621614                 7209(100%)                   M20273                159_7368                    94.6%                      100.0%                                                                                                                                                                                                             
  P18                             MF621615                 5511 (84.4%)                 M20273                150_6672                    94.7%                      100%[\*](#t001fn001){ref-type="table-fn"}                                                                                                                                                                          
  *Kobuvirus*                     * Aichivirus A*          * *                          P4                    MG009596                    7917 (98.2%)               FJ890523                                     3_8059                                       96.4%                                          98.6%[\*](#t001fn001){ref-type="table-fn"}                                
  P6                              MG692430                 4213 (57.1%)                 FJ890523              411_7780                    96.3%                                                                                                                                                                                                                                         
  P9                              MG692431                 5632 (72.7%)                 FJ890523              226_7966                    96.6%                                                                                                                                                                                                                                         
  P24                             MG692432                 3322 (63.4%)                 FJ890523              407_5644                    96.6%                                                                                                                                                                                                                                         
  *Salivirus*                     *Salivirus*              * *                          P2                    MG026493                    6452 (93.1%)               KT240115                                     968_7895                                     91.0%                                          92.3%                                                                     
  P3                              MG692420-21              1476 (49.2%)                 KT310068              4519_7512                   96.5%                                                                                                                                                                                                                                         
  P6                              MG026494                 6866 (100%)                  KT310068              955_7820                    95.8%                      97.1%                                                                                                                                                                                                              
  P14                             MG026495                 7587 (99.7%)                 KT310068              225_7827                    95.6%                      97.1%                                                                                                                                                                                                              
  P25                             MG692422-24              1082 (23%)                   KM023140              1730_6292                   91.3%                                                                                                                                                                                                                                         
  P26                             MG692425-28              2034 (45.8%)                 KT310068              1087_5520                   93.4%                                                                                                                                                                                                                                         
  P27                             MG692429                 459 (100%)                   KT310068              3043_3501                   95.4%                                                                                                                                                                                                                                         
  P28                             MG026496                 7440 (95%)                   NC_012957             8_7839                      91.1%                      95.5%[\*](#t001fn001){ref-type="table-fn"}                                                                                                                                                                         
                                  *Orf1*                   *Orf2*                                             RdRp region nt similarity                                                                                                                                                                                                                                                 
  ***Caliciviridae***             *Norovirus*              *Norwalk virus*              *Norovirus GI*        *GI*.*3*                    *GI*.*3*                   P8                                           MG557648                                     6257 (85.2%)                                   KJ196292                                     272_7613             89.5%   91.8%[\*\*](#t001fn002){ref-type="table-fn"}
  *GI*.*7*                        * *                      P10                          MG572183              588 (98.5%)                 KU311161                   4803_5390                                    86.1%                                        85.6%[\*\*](#t001fn002){ref-type="table-fn"}                                                                             
  *GI*.*7*                        *GI*.*7*                 12                           MG557649              4663 (72.5%)                KU311161                   369_6795                                     92.6%                                        94.5%[\*\*](#t001fn002){ref-type="table-fn"}                                                                             
  *GI*.*3*                        *GI*.*3*                 P15                          MG557650              7425 (100%)                 KJ196292                   74_7498                                      89.4%                                        91.4%[\*\*](#t001fn002){ref-type="table-fn"}                                                                             
  *GI*.*7*                        *GI*.*7*                 P20                          MG557651              7012 (95.3%)                KU311161                   1_7351                                       91.1%                                        90%[\*\*](#t001fn002){ref-type="table-fn"}                                                                               
  *GI*.*6*                        *GI*.*6*                 P26                          MG557652              4702 (66%)                  AF093797                   392_7498                                     91.1%                                        91%[\*\*](#t001fn002){ref-type="table-fn"}                                                                               
  *Norovirus GII*                 *GII*.*7*                *GII*.*6*                    P3                    MG557654                    7236 (100%)                KU935739                                     179_7414                                     97.8%                                          98.9%                                                                     
  *GII*.*e*                       *GII*.*10*               P4                           MG557655              6351 (100%)                 JX459907                   236_6595                                     86.5%                                        95.5%                                                                                                                    
  *GII*.*7*                       *GII*.*9*                P6                           MG557656              2999 (58%)                  AB039777                   68_5180                                      89.2%                                        91.8%[\*\*](#t001fn002){ref-type="table-fn"}                                                                             
  * *                             * *                      P8                           MG557653              3388 (79.5%)                EF187497                   422_4681                                     82.0%                                                                                                                                                                 
  *GII*.*e*                       *GII*.*4*                P11                          MG557657              4508 (64.4%)                JX459907                   356_7345                                     95.3%                                        96%[\*\*](#t001fn002){ref-type="table-fn"}                                                                               
  *Sapovirus*                     *Sapporo_virus*          *Sapporo_virus*              P5                    MG692435                    3804 (58.4%)               AJ249939                                     350_6856                                     94.8%                                                                                                                    
  P19                             MG692436                 3898 (54.4%)                 AJ249939              152_7311                    95.0%                                                                                                                                                                                                                                         
  24                              MG692437                 3162 (55.9%)                 AY237420              686_6337                    94.9%                                                                                                                                                                                                                                         
  ** **                           aa identity to NS1                                                                                                                                                                                                                                                                                                                                    
  ***Parvoviridae***              *Bocaparvovirus*         *Primate_bocaparvovirus_1*   *Human_bocavirus_1*   P20                         MG383449                   5155 (100%)                                  KX373884                                     121_5275                                       99.4%                                        99.7%                        
  *Human_bocavirus_3*             P2                       MG383445                     4195 (87.8%)          FJ973562                    133_4912                   95.6%                                        98.5%                                                                                                                                                                 
  P27                             MG522845-6               1065 (40%)                   KM624026.1            2354_5003                   97.3%                                                                                                                                                                                                                                         
  *Primate\_\_bocaparvovirus_2*   *Human_bocavirus_2*      P4                           MG383447              5204 (100%)                 EU082213                   1_5204                                       98.8%                                        99.8%                                                                                                                    
  P9                              MG522843                 562 (100%)                   EU082213              2081_2642                   98.8%                                                                                                                                                                                                                                         
  P12                             MG522844                 652 (100%)                   EU082213              2066_2717                   98.6%                                                                                                                                                                                                                                         
  P15                             MG383448                 3401 (72.1%)                 EU082213              434_5149                    96.5%                                                                                                                                                                                                                                         
  P25                             MG383450                 5155 (100%)                  FJ170279              1_5172                      98.4%                      100.0%                                                                                                                                                                                                             
  *Human_bocavirus_4*             P3                       MG383446                     5269 (100%)           KC461233                    49_5207                    99.3%                                        99.8%                                                                                                                                                                 
  P29                             MG522847                 2538 (66.4%)                 KC461233              480_4299                    99.2%                                                                                                                                                                                                                                         
  *None*                          *Bufavirus-3*            *Bufavirus-3*                P4                    MG550916                    321 (100%)                 AB982221                                     3895_4215                                    97.0%                                                                                                                    
  P16                             MG550917                 183 (100%)                   AB982221              2416_2598                   96.7%                                                                                                                                                                                                                                         
  ***Picobirnaviridae***          *Picobirnavirus*         * *                          *Picobirnavirus*      P6                          MG522848                   447 (87%)                                    KJ206568.1                                   724_1236                                       91.0%                                                                     
  P25                             MG522849                 474 (100%)                   AF246939.1            667_1140                    91.0%                                                                                                                                                                                                                                         

\*3--29% gaps in VP1 protein alignments,

\*\*1 to 67% gaps in RdRp region nucleotide alignments

Ethics statement {#sec018}
----------------

Ethical committees at the University of California (San Francisco, CA, USA); Emory University (Atlanta, GA, USA); The Food, Medicine and Health Care Administration and Control Authority of Ethiopia; and the Ethiopian Ministry of Science and Technology granted approval for this study. We obtained verbal informed consent in Amharic from the parent or guardian of each study participant.

Results {#sec019}
=======

Characteristics of study population {#sec020}
-----------------------------------

A flow diagram of sampling and participation is shown ([Fig 1](#pone.0202054.g001){ref-type="fig"}). Of 446 censored children who were eligible to participate, 317 children presented for the study visit examination and 269 provided stool samples. The mean age of children with stool samples was 2.7 years old, 56.5% (152/269) of children were female.

![Flow diagram for collection of fecal samples.](pone.0202054.g001){#pone.0202054.g001}

Pools of fecal samples were then processed by filtration and nuclease treatment to digest non-capsid protected nucleic acids. Viral genomes where then extracted and DNA and RNA randomly amplified and sequenced on the Illumina MiSeq platform (250 bases paired end reads). A total number of 27.8 million reads were generated for an average number of reads of approximately one million per pool. The raw sequence data for each pool is available at NCBI's Short Reads Archive under GenBank accession number **SRP120619**.

The most commonly detected viral reads belonged to the *Picornaviridae* family which were detected in 27/29 (93.1%) pools. 0.90% (249,982) of 27.8 million total sequence reads, were found to encode *Picornaviridae* related proteins (E scores \<10^−10^). The fraction of the 29 sample pools analyzed that were positive for members of six different *Picornaviridae* genera were: Enterovirus (72.4%), Parechovirus (41.3%), Cosavirus (41.3%), Salivirus (27.5%), Kobuvirus (13.7%), and Hepatovirus (13.7%). Next in prevalence, *Caliciviridae* family members were detected in 44.8% of pools and consisted of norovirus GI (20.6%), norovirus GII (17.2%) and sapporovirus (10.3%). *Parvoviridae* family members were also detected in 41.3% of the pools including primate bocaparvovirus 1 and 2 (34.4%), adeno-associated virus 2 (13.7%), and bufavirus 3 (6.8%). In the *Adenoviridae* family human_mastadenoviruses A species (HAdV-A) was detected in 17.2% of pools, HAdV-C in 10.3%, HAdV-D in 13.7%, and HAdV-F in 3.4%. Picobirnavirus sequences were found in 2/29 (6.8%) of the pools. No rotavirus nor astrovirus sequence reads were detected. The fraction of total reads from each pool encoding proteins with high-level similarity (E scores \<10^−10^) to different human viruses is shown ([Fig 2](#pone.0202054.g002){ref-type="fig"}).

![Distribution of viral sequences reads to named viruses using BLASTx E score \<10^−10^.](pone.0202054.g002){#pone.0202054.g002}

For the viruses that yielded the largest number of reads complete or more partial genome sequences were separately assembled from each of the 29 libraries. Nucleotide sequence reads from each library were aligned against the GenBank available genomes that showed the greatest translated protein similarity. Single large contigs of nearly complete genomes, or multiple contigs aligned to the same reference genome but with gaps remaining between mapped segments, were generated ([Table 1](#pone.0202054.t001){ref-type="table"}). These assembled viral sequences were then compared to taxonomically classified genomes. The results are presented as % amino acid identity for proteins used for genotype classification (VP1 of picornaviruses) or when not available as % nucleotide identity determined using BLASTn ([Table 1](#pone.0202054.t001){ref-type="table"}).

Family *Picornaviridae*: Enteroviruses {#sec021}
--------------------------------------

Thirty one near complete or partial enterovirus genomes ranging in size from 891 nucleotides (nt) to 7,392 nt were generated, 17 of which included the VP1 capsid region. A phylogenetic analysis of the VP1 of enteroviruses and other *Picornaviridae* genera is shown ([Fig 3](#pone.0202054.g003){ref-type="fig"}).

![Phylogenetic analysis of VP1s from different genera of the *Picornaviridae* family.\
Viral sequences described here are highlighted by black diamonds.](pone.0202054.g003){#pone.0202054.g003}

### Enterovirus species A {#sec022}

Seven enterovirus A infections were identified. Two enterovirus A (EV-A) Coxsackievirus A16 (CV_A16) sequences from different pools showed 99.3% VP1 region amino acid closest identity to CV-A16 genomes in GenBank. Five other EV-A sequences without VP1 capsid region showed 82.1 to 85% nucleotide closest identity to three different enterovirus species A genotypes yielding three genotypes Coxsackievirus A6, one Coxsackievirus A14, and another Coxsackievirus A16 partial genomes. The two CV_A16 with VP1 showed 0 amino acid substitution per site and their available genome sequences ([Table 1](#pone.0202054.t001){ref-type="table"}) shared 99.3% overall similarity indicating a recent common origin.

### Enterovirus species B {#sec023}

Twelve enterovirus B infections were identified. Seven enterovirus B (EV-B) contigs containing the VP1 capsid region were generated. These sequences showed 89.2 to 97.2% VP1 region amino acid closest identity to five different enterovirus B genotypes (two Echovirus E14, one Echovirus E16, one Echovirus E18, two Echovirus E19, and one Echovirus E27) reported in GenBank ([Table 1](#pone.0202054.t001){ref-type="table"}). The genotypes detected twice (echovirus E14 and E19) with complete polyprotein coding genome regions showed 0.025 and 0.006 amino acid substitutions per site respectively. Pair-wise alignment showed nucleotide identity of 90.5 and 94.0% similarities respectively. Five EV-B sequence contigs without VP1 capsid region showed 82 to 85.4% nucleotide identity to three enterovirus B genotypes (two echovirus E6, one echovirus E16, and two echovirus E18) reported in GenBank ([Table 1](#pone.0202054.t001){ref-type="table"}).

### Enterovirus species C {#sec024}

Twelve enterovirus C infections were identified. Four different genotypes of enterovirus C (EV-C) were detected showing 89 to 98.3% VP1 region amino acid identity to reference enterovirus C genotypes. One Coxsackievirus CV-A1, one EV-C99, three Coxsackievirus CV-A17, and three Coxsackievirus CV-A20 viruses could be identified. The complete VP1 coding sequences of the twice detected CV-A17 (excluding the more divergent CV-A17 from pool 9) and the thrice detected CV-A20 showed 0.012 and 0.0--0.012 amino acid substitutions per site respectively. Pair-wise alignment showed nucleotide identity of 98.0 and 94.6--98.3% similarities respectively again reflecting a recent common origin. Four other EV-C sequence contigs without VP1 capsid region showed 79 to 85% nucleotide identity to enterovirus C genotypes (coxsackievirus A13, coxsackievirus A17, coxsackievirus A20, enterovirus C99) reported in GenBank ([Table 1](#pone.0202054.t001){ref-type="table"}).

Family *Picornaviridae*: Parechoviruses {#sec025}
---------------------------------------

Twelve human parechovirus infections were detected, 10 of which generated complete VP1 sequences. Six VP1 showed closest amino acid identity (96.1 to 96.9%) to human parechovirus 1 (HPeV1). One HPeV5, one HPeV6, one HPeV8, and one HPeV17 viral sequences were also detected showing closest amino acid identity of 92.8, 95.8, 97.6 and 97.3% respectively to their respective genotype VP1. The two non-VP1 contigs showed 89.2 and 88.2% nucleotide identity to HPeV1 and HPeV4. Two pairs of very closely related HPeV-1 VP1 sequences showed 0.006--0.008 amino acid substitutions per site. When their contigs were compared they showed nucleotide similarities of 98.3 and 98.5% indicating a recent common origin for both pairs.

Family *Picornaviridae*: Hepatoviruses {#sec026}
--------------------------------------

Four hepatovirus A infections were detected. Four of the observed contigs included the VP1 region and showed closest amino acid identity from 99.5 to 100% to hepatovirus A genotype IB genome available in GenBank. When the four contigs were aligned, their overlapping regions showed nucleotide identity of 95.2--99.9%. Two pairs of very closely related hepatovirus A VP1 sequences showed 0.006 and 0.008 amino acid substitution per site, respectively. When their contigs were compared they showed nucleotide similarities of 95.4 and 99.7%, respectively indicating a recent common origin for both pairs.

Family *Picornaviridae*: Saliviruses {#sec027}
------------------------------------

Eight salivirus infections were detected, 4 of which included the VP1 capsid region. Three sequences showed 92.3 to 97.1% VP1 amino acid identity to Salivirus_A strain GUT/2009/A-1746 from Guatemala, while the fourth VP1 was closest (95.5%) to Salivirus_NG-J1 from Nigeria. These four contigs of nearly complete coding sequences showed 87.3 and 98% nucleotide identity over at least 6452 bp. Four other contigs showed 91.3 to 96.5% nucleotide identity to other salivirus strains reported in GenBank. Three saliviruses with very closely related VP1 sequences (excluding the more divergent pool 2 salivirus) showed 0--0.06 amino acid substitutions per site. These 3 contigs showed nucleotide similarities of 97.8--99.3% similarity, again indicating a recent common origin for these 3 viruses.

Family *Picornaviridae*: Kobuviruses {#sec028}
------------------------------------

Four kobuvirus infections were detected, only 1 of which included the VP1 capsid region. This VP1 showed 98.6% region amino acid identity to Aichi virus 1 isolate Chshc7 from China. The three other viral sequences showed nucleotide identity of 96.3 to 96.6% to other Aichi viruses 1.

Family *Picornaviridae*: Cosaviruses {#sec029}
------------------------------------

Thirteen cosavirus infections were detected. Four of these sequences included the VP1 region and showed closest amino acid identities of 97, 98.2, 96.8 and 94.5%, respectively, to an HCoSV_A5 genotype, HCoSV_A8 genotype, HCoSV_A12 genotype, and HCoSV_D1 genotype. Nine cosavirus sequences without VP1 capsid region showed 85.9 to 91.9% nucleotide identity to Cosavirus A (six sequences), cosavirus E (one sequence) and cosavirus E/D (two sequences) reported in GenBank. In total, 9 HCoSV_A (species A), 1 HCoSV_D, 2 HCoSV_E/D, and 1 HCoSV_E viral sequences, were identified and the near complete or partial genomes submitted to GenBank.

Family *Caliciviridae* {#sec030}
----------------------

Eleven noroviruses viral infections were detected, 10 of which included the regions used for genogroup determination (partial RdRp) and 9 also included ORF2 for capsid genotyping. To determine genogroups and capsid genotypes the Norovirus Genotyping Tool was used \[[@pone.0202054.ref020]\]. 5 genogroup I (two GI.P3, two GI.P7, and one GI.P6) and 4 genogroup II (two GII.Pe and two GII.P7) were identified. The ORF2 genotyping results were identical for GI but for GII viruses genotypes GII.6, GII.10, GII.9, and GII.4_Sydney_2012 capsid were reported. A phylogenetic analysis of the partial RdRp region of these noroviruses is shown ([Fig 4](#pone.0202054.g004){ref-type="fig"}).

![Phylogenetic analysis of RdRp from different genotypes of noroviruses.\
Viral sequences described here are highlighted by black diamonds.](pone.0202054.g004){#pone.0202054.g004}

Three Sapporo virus sequences were also found which showed 94.8--95% nucleotide identity to SLV/Bristol/98/UK and Sapovirus Mc10. The overlapping region of the 3 contigs showed nucleotide identities of 72 to 99.5%.

Family *Parvoviridae*: Bocaparvovirus {#sec031}
-------------------------------------

A total of ten bocavirus infections were detected. Five bocavirus NS1 contigs were generated which showed closest amino acid identity of 99.7% to HBoV_1, two showed closest amino acid identity of 99.8--100% to HBoV_2 genome~~,~~ one showed closest amino acid identity of 98.5% to an HBoV_3 genome~~,~~ and one showed closest amino acid identity of 99.8% to HBoV_4. Five non-NS1 containing contigs, three showed 96.5--98.8%, one showed 97.3%, and one showed 99.2% nucleotide identity to HBoV2, HBoV3 and HBoV4 respectively. All together, we detected one bocavirus 1, five bocavirus 2, and two bocavirus 3 and two bocavirus 4.

Family *Parvoviridae*: [Dependoparvovirus]{.ul} {#sec032}
-----------------------------------------------

Four contigs of adeno-associated virus_2 in the dependoparvovirus genus ranging in size from 2730 nt to 4377 nt were identified. Their overlapping region showed a nucleotide similarity of 96.9 to 99.6%.

Family *Parvoviridae*: [Protoparvovirus]{.ul} {#sec033}
---------------------------------------------

Two short contigs of bufavirus 3 in two pools were also identified with 96.7--97% nucleotide identity to bufavirus-3 in GenBank.

Families *Adenoviridae*, *Anelloviridae*, *Picobirnaviridae* {#sec034}
------------------------------------------------------------

Sequences from human_mastadenoviruses A species (HAdV-A), HAdV-C, HAdV-D, and HAdV-F in the *Adenoviridae* family ranging in size from 250 nt to 6282 nt, from 1068 nt to 6829 nt, from 250nt to 980 nt, and of 1153 nt were identified in five, three, four, and one pool, respectively.

Two human picobirnavirus contigs, of 474 nt and 513 nt were also generated which both showed 91% nucleotide identity with human picobirnavirus strain 1-CHN-97 and human picobirnavirus VS6600008 respectively.

Viral families of unknown host tropism {#sec035}
--------------------------------------

Also generated were nearly complete genomes of ss+RNA posaviruses and husaviruses, both members of the order *Picornavirales*. Contigs related to the *Smacoviridae* family and related genome named hudisaviruses both members of the highly diverse group known as CRESS-DNA viruses (Circular Rep-encoding ss DNA genomes) were also detected ([S1 Table](#pone.0202054.s001){ref-type="supplementary-material"}). These viruses have been described in human fecal samples but since their cellular host tropisms remain unknown they have not been included in the subsequent virome comparison analysis.

Virome comparison in control and intervention groups {#sec036}
----------------------------------------------------

The median number of different human viruses present per pool was 5.5 (IQR 3.25--6.75) in the intervention arm and 3.0 (IQR 2.5--6.0) in the control arm ([Fig 5](#pone.0202054.g005){ref-type="fig"}). There was no visual signal for a difference in alpha diversity of the human enteric virome between the intervention and control arm ([Fig 6](#pone.0202054.g006){ref-type="fig"}). For each of the three evaluated distance metrics, p-values from the Kruskal-Wallis test evaluating the differences in alpha diversity by intervention arm were non-significant: Richness (observed), p = 0.2893; Shannon, p = 0.2559; and Simpson, p = 0.162.

![Median and IQR for number of distinct viruses detected per pool of the intervention and control groups.](pone.0202054.g005){#pone.0202054.g005}

![Differences in alpha diversity for the enteric virome between intervention and control groups.](pone.0202054.g006){#pone.0202054.g006}

Discussion {#sec037}
==========

The high diversity of enteric viruses described in 269 children from 14 Ethiopian villages represents the first description of the enteric virome of East African children. Prior studies in that region have relied on the use of PCR or antigen detection targeting restricted subsets of enteric viruses \[[@pone.0202054.ref021]--[@pone.0202054.ref024]\].

The fecal samples analyzed were collected as part of a cluster-randomized trial of a water-improvement intervention. Children participating in this trial were randomly sampled from a population census and thus the viromes characterized here are broadly representative for children \<5 years old from the Goncha region of Northern Ethiopia in 2016. Availability of this data set can therefore be considered a baseline against which future viromes in that population can be compared to identify sequence changes in the most common viruses and help identify newly introduced or emerging viruses.

The great majority of sequence reads here mapped to RNA viruses of the *Picornaviridae* and *Caliciviridae* families. Picornaviruses showed a particularly high level of genetic diversity including multiple genera, species, and genotypes particularly in the enterovirus, cosavirus, and parechovirus genera. Some picornaviruses had nearly identical VP1 and very closely related genomes (\>95%). This high level of similarity between variants from different children reflects recent common origins and point towards those genotypes that, due to either immune, viral, or environmental factors may be spreading particularly efficiently.

Beside picornaviruses, other RNA (caliciviruses, picobirnaviruses) and DNA (adenoviruses, parvoviruses, and anelloviruses) viruses were also detected. Rotavirus sequences were not detected. Globally rotavirus remains a leading cause of severe acute water diarrhea but has shown a significant decline in vaccine age-eligible children in Africa following introduction of rotavirus vaccination \[[@pone.0202054.ref025], [@pone.0202054.ref026]\]. Ethiopia initiated a vaccination campaign in 2013 with an estimated coverage of 85% by 2015 \[[@pone.0202054.ref026]\], We did not detect any rotavirus in the sample, which may be an indication of successful recent vaccination campaigns or because this was a population-based sample and may not have captured children ill with rotavirus infections. Astroviruses are also common enteric childhood enteric infections \[[@pone.0202054.ref027]--[@pone.0202054.ref030]\] but none was detected among the population sampled.

Metagenomic studies limited to DNA viruses of feces from 65 rural Kenyan adults with and without HIV infections showed a more restricted virome consisting of adenovirus D, anelloviruses, and papillomaviruses (the last in a single sample)\[[@pone.0202054.ref031]\]. Reads belonging to the *Circoviridae* family (members of the CRESS-DNA group) were also reported but circoviruses have not been shown to replicate in humans and therefore may represent genomes related to other CRESS-DNA viruses such as the smacoviruses described above. A greater fraction of adenovirus reads could be measured in AIDS patients with CD4 counts \<200. The greater number of viral families detected in the current study may be due to greater susceptibility or exposure of children versus adults, socio-economic or geographic difference, and/or the unbiased amplification methods used which targeted only DNA viruses. While we also found adenovirus and anellovirus sequences numerous genera from the DNA *Parvoviridae* family were also detected here. A metagenomics fecal virome study of Malawian twin infants with severe acute malnutrition was also restricted to DNA viruses \[[@pone.0202054.ref032]\]. The human viruses reported were the ubiquitous anelloviruses, parvoviruses (bocaviruses and dependoviruses), as well as very low levels of papillomavirus and polyomavirus \[[@pone.0202054.ref032]\].

Viral genomes of unknown cellular origins were detected namely ssRNA+ posaviruses and husaviruses and circular ssDNA smacoviruses and hudisaviruses, all previously reported in human feces. Based on sequence similarity to cDNA from the long worm of pig (Ascaris suum), posaviruses from feces of pigs \[[@pone.0202054.ref033]--[@pone.0202054.ref037]\] and other mammals \[[@pone.0202054.ref038]\] have been hypothesized to infect nematodes present in their intestinal track \[[@pone.0202054.ref033]\]. This possibility was reinforced by the recent description of a similar genome (Hubei picorna-like virus 11) (YP_009336580) showing 80% protein identity to a posavirus sequenced here from a large pig roundworm from China \[[@pone.0202054.ref039]\]. The detection of posaviruses may therefore reflect the presence of enteric nematodes in Ethiopian children, a frequent occurrence in that country \[[@pone.0202054.ref040]\]. Husaviruses are distantly related to posaviruses with a similar RNA genome organization and also phylogenetically located in the *Picornavirales* order \[[@pone.0202054.ref041]\]. Husaviruses were originally detected in feces from men in Amsterdam (HIV positive and negative) and more recently in Vietnamese human and pig feces ([BAV31552.1](https://www.ncbi.nlm.nih.gov/protein/1047210411?report=genbank&log$=prottop&blast_rank=1&RID=0TWZBDKZ014)) \[[@pone.0202054.ref038]\]. While their cellular host(s) are also unknown these related member of the *Picornavirales* order, which also includes fisaviruses from fish gut content \[[@pone.0202054.ref042]\], rasavirus from rat feces \[[@pone.0202054.ref038]\], and basavirus from bat feces \[[@pone.0202054.ref038]\], share a nucleotide composition which groups them with members of that viral order known to infect arthropods \[[@pone.0202054.ref038]\]. Nematodes and arthropods, both with exoskeleton principally made of chitin, are phylogenetically related and both members of the Ecdysozoa superphylum.

Smacoviruses and hudisaviruses make up two subgroups of the highly diverse CRESS-DNA viruses whose known cellular hosts range from mammals (Circoviridae) and plants (Geminiviridae) to fungi (SsHADV)\[[@pone.0202054.ref043]\]. Originally described in feces of chimpanzees \[[@pone.0202054.ref044]\], smacovirus genomes have also been reported in feces from other non-human primates and humans \[[@pone.0202054.ref045]\], pigs \[[@pone.0202054.ref046]--[@pone.0202054.ref048]\] other mammals \[[@pone.0202054.ref049]--[@pone.0202054.ref051]\] and a bird \[[@pone.0202054.ref052]\]. Hudisavirus DNA has also been reported in human and macaque feces \[[@pone.0202054.ref053], [@pone.0202054.ref054]\]. As for the large majority of the recently described CRESS-DNA genomes the cellular tropism of the smacoviruses and hudisaviruses genomes detected here remains unknown and could consist of human intestinal epithelial cells, parasites in the gut, or originate from viruses in consumed food products.

The viruses detected here represent minimum values for these children's viromes. It is possible that some viral nucleic acids may have gone undetected due to viral loads being below detection levels. The same library making method and sequencing depth was used for both intervention and control fecal samples that were processed in an interdigitated manner. Limitations of the metagenomics approach used here should therefore equally impact results from both groups.

The human enteric viruses genetically characterized here are transmitted by fecal-oral transmission and also for adenoviruses by the respiratory route. Because enteric viral infections and fecal shedding are typically acute events of limited duration it is unlikely that the viral nucleic acids detected in our 2016 sampling originate from chronic infections initiated prior to the start of the clean water intervention in 2014.

While we did not detect a difference between the prevalence of different virus families nor the median count of viruses across the control and intervention groups of the water improvement trial, we are wary to conclude that the intervention had no effect on the enteric virome. With samples from 269 children in 29 pools, we were likely underpowered to detect a difference between groups. Indeed, with a post-hoc power calculation we had 60% power to discern a 40% difference in richness and just 18% power to discern a 20% difference. Moreover, the fidelity of the intervention was suboptimal. One of the study intervention wells never hit water, two were functional in the wet season only and one was not functional after three months. Large public health intervention trials are challenging in very resource-limited settings and a more robust durable water improvement intervention may have shown a reduction in viral transmission. Moreover, clean water is not the only viral transmission pathway of interest. This study provides no information on the role of sanitation facilities, poor hygiene, contaminated food products, or limited sterilization during cooking. Finally, the laboratory staff was not masked to treatment allocation of the trial.

In summary, we provide here a description of the enteric virome of East African children. Expanded use of human virome characterization holds promise to measure changes in viral transmissions resulting from natural phenomena or human interventions.
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======================

###### Characteristics of contigs from viruses of unknown tropism.
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Click here for additional data file.
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